An interventional study of Continuous Compartmental Pressure Monitor in Proximal Tibia Fracture, Tibial Shaft Fracture and Acute Compartment Syndrome, sponsored by Boston Children's Hospital. Recruiting at 1 site in United States. Open to participants aged 10 Years to 21 Years. Per ClinicalTrials.gov, last updated 2026-10-23.
Sponsored by Boston Children's Hospital · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 50 studies in Tibial Fractures with a site in United States — 15 open to participants now, 18 under way, 3 of them phase 3. Tibial Fractures · United States.
Among the 50 studies in Tibial Fractures with a site in United States, this one is the 20th largest by planned enrollment of the 38 interventional ones that give a count, is the only one that started in 2026, is one of 27 with no phase, reaches primary completion later than 13 of the 17 other live ones, and was the 49th registered.
136 studies on the registry are indexed under Tibial Fractures; 38 are open to participants now.
Browse Tibial Fractures studies →15 of the 50 studies in Tibial Fractures with a site in United States are open now. Recruiting first, the newest first:
Brigham and Women's Hospital · Sites in United States
Ages 18+
University of Chicago · Sites in United States
Ages 18+
University of Alabama at Birmingham · Sites in United States
Ages 18–85
Major Extremity Trauma Research Consortium · Sites in United States
Ages 18+
Denver Health and Hospital Authority · Sites in United States
Ages 18–100 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 27 Tibial Fractures studies recruiting now, 13 (48%) set no upper age limit and 7 (26%) stop at 75 or younger; 5 take children under 18; 4 take healthy volunteers.
This study: 10 Years to 21 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
50 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 3 · Phase 3 5 · Phase 4 4
First in 2002; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 66 across 92 interventional studies indexed under Tibial Fractures.
Median enrollment 53 across the 38 interventional studies, 97 across the 12 observational. Of the 28 that completed or were terminated, 9 (32%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 50 have an industry lead sponsor. The 10 most frequent:
Boston Children's Hospital is the lead sponsor of 609 studies on the registry; 148 are open to participants now.
Of its 32 completed or terminated interventional studies of FDA-regulated products, 19 (59%) have results posted.
Boston Children's Hospital has 1 study filed under Tibial Fractures — fewer than ten, so there is no comparison to draw.
8 of the studies in Tibial Fractures with a site in United States that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05000281Phase 3Major Extremity Trauma Research ConsortiumEffect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures | 2026-11-30 |
| NCT05766670Phase 3Wake Forest University Health SciencesIntramedullary Calcium Sulfate Antibiotic Depot | 2027-01 |
| NCT05421741Wake Forest University Health SciencesProphylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial | 2026-12 |
| NCT04113044AO Innovation Translation CenterGo Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS® | 2026-12-31 |
| NCT06679049University of Alabama at BirminghamComparison of Healing Measures Tibial Fractures Following Standard Intramedullary Nailing or Micromotion Tibial Intramedullary Nailing | 2027-01-31 |
Add all 8 to your calendar (.ics) → With an account.
Among the 50 studies in Tibial Fractures with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn more about anterior leg compartment pressures in adolescents who have sustained tibia fractures. It will also examine whether measuring anterior compartment pressure helps physicians diagnose acute compartment syndrome (ACS), a rare but dangerous complication that can develop following surgical treatment of a tibia fracture.
The main questions it aims to answer are:
Participants will have a continuous pressure monitoring sensor placed in their knee anterior knee compartment during their surgery. This sensor will record pressure data following a patient's surgical treatment for 18+ hours.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
All study participants will have an MY01 medical device inserted to record continuous anterior compartment pressure data.
Device: Continuous Compartmental Pressure Monitor
All study participants will have a continuous compartmental pressure monitor placed in the operating room. The pressure sensor will be inserted into the anterior knee compartment, and will remain in place for a minimum of 18 hours postoperatively.
Continuous anterior compartment pressure
The primary outcome will be continuous anterior compartment pressure measurements, recorded in millimeters of mercury (mmHg) by the MY01 device.
Time frame: From the placement of the MY01 device sensor to 18 hours postoperatively
Development of acute compartment syndrome
The secondary outcome will be the development of acute compartment syndrome, defined as a clinically diagnosed ACS requiring surgical fasciotomy during index hospitalization. This outcome will be analyzed as a binary variable.
Time frame: From MY01 device insertion to index hospital discharge, up to 1 week postoperatively
Neurovascular status
The third outcome will be clinical neurovascular status at the initial postop visit. This will be defined as a well-perfused limb with normal distal motor and sensory function as described in the clinical note. This outcome will be analyzed as a binary variable (normal neurovascular status or abnormal neurovascular status). Abnormal neurovascular status will subsequently be defined as the presence of any of the following: abnormal motor function, abnormal sensory function, and/or abnormal vascular status.
Time frame: First clinic visit following hospital discharge, average of 2-4 weeks postoperatively
Plan to share: Undecided
Started Aug 2026 (actual). Primary completion is estimated for Jun 2028, 21 months after the start.
Of 39 interventional studies with no phase under Tibial Fractures, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 80. This study's planned 21 months is below that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.